Cannabichromenic Acid (CBC-a) Research Dashboard
Double-blind human trials
Clinical human trials
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 13 studies associated with Cannabichromenic Acid (CBC-a).
Here is a small sampling of Cannabichromenic Acid (CBC-a) studies by title:
- In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transporters
- Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome
- Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels
- Rapid Antibacterial Activity of Cannabichromenic Acid against Methicillin-Resistant Staphylococcus aureus
- Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews
Components of the Cannabichromenic Acid (CBC-a) Research Dashboard
- Top medical conditions associated with Cannabichromenic Acid (CBC-a)
- Proven effects in clinical trials for Cannabichromenic Acid (CBC-a)
- Receptors associated with Cannabichromenic Acid (CBC-a)
- Individual study details for Cannabichromenic Acid (CBC-a)
Ready to become a subscriber? Go to our PRICING page.
Members can filter by the following criteria:
- Study Type
- Organ Systems
- Study Result
- Year of Publication
Overview - Cannabichromenic Acid (CBC-a)
Description of Cannabichromenic Acid (CBC-a)
The plant-based (phytocannabinoid) Cannabichromenic acid was discovered in 1998. It is the precursor to CBC.
Cannabichromenic acid, (+)-Cannabichromenic acid
IUPAC Name: 5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromene-6-carboxylic acid
Molecular Formula: C22H30O4
Cannabichromenic Acid (CBC-a) Properties and Effects
• Anti-microbial (bacteria, fungi)
Cannabichromenic Acid (CBC-a) Receptor Binding
No current data available
Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.